在三角形和欧米克朗BA.1浪潮期间,mRNA疫苗接种和SARS-CoV-2感染之间的关联:人口水平分析
Allison P Plaxco1,2, Jennifer M Kmet1, Vikki G Nolan2
1Bureau of Epidemiology, Preparedness, and Informatics, Shelby County Health Department, Memphis, Tennessee.
AJPM focus
|November 9, 2023
概括
针对Omicron变种的COVID-19疫苗的有效性因年龄组而异,不同于Delta变种激增期间. 这表明与年龄相关的SARS-CoV-2菌株防护的差异.
科学领域:
- 流行病学 流行病学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- COVID-19 mRNA疫苗对SARS-CoV-2 Omicron变种的有效性有所降低.
- 之前的研究表明,在Omicron激增期间,与年龄相关的疫苗有效性差异存在,但对于其他变种没有观察到这种情况.
研究的目的:
- 在SARS-CoV-2的Delta和Omicron BA.1波中,根据年龄组比较疫苗的有效性.
- 为了确定年龄是否会在主要的SARS-CoV-2菌株中不同影响COVID-19疫苗的有效性.
主要方法:
- 利用了田纳西州谢尔比县的COVID-19监控数据.
- 参与者分层分成年龄组:18-34岁,35-64岁和65岁以上.
- 疫苗接种情况分类:未接种疫苗,完全接种疫苗和完全接种疫苗 + 强剂.
主要成果:
- 在所有接种疫苗的群体中,COVID-19的发病率在奥米克朗波期间明显高于德尔塔波.
- 在三角洲疫情浪潮期间,完全接种疫苗的个体的病例减少了79.2%,接种增强剂的个体的病例减少了94.8%,与未接种疫苗的个体相比.
- 在Omicron浪潮期间,与未接种疫苗的个人相比,完全接种疫苗的个体的病例减少了40.2%,并且那些接种了增强剂的个体的病例减少了66.7%.
结论:
- 疫苗对COVID-19的有效性在Omicron浪潮期间显示出与年龄相关的差异,而在Delta浪潮期间这种模式并不明显.
- 建议进行进一步的研究,以探索影响特定年龄疫苗有效性的行为模式和其他混因素.
相关概念视频
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Viruses with RNA Genomes
34
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
34
Cross-reactivity
31.2K
Overview
31.2K


